RJA
PFE icon

Raymond James & Associates’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$238M Sell
8,209,415
-349,305
-4% -$10.1M 0.14% 123
2024
Q2
$239M Sell
8,558,720
-204,765
-2% -$5.73M 0.16% 106
2024
Q1
$243M Buy
8,763,485
+925,960
+12% +$25.7M 0.16% 102
2023
Q4
$226M Sell
7,837,525
-771,857
-9% -$22.2M 0.17% 106
2023
Q3
$286M Sell
8,609,382
-135,019
-2% -$4.48M 0.24% 73
2023
Q2
$321M Sell
8,744,401
-109,770
-1% -$4.03M 0.26% 68
2023
Q1
$361M Buy
8,854,171
+311,509
+4% +$12.7M 0.31% 59
2022
Q4
$438M Buy
8,542,662
+348,547
+4% +$17.9M 0.4% 44
2022
Q3
$359M Buy
8,194,115
+164,241
+2% +$7.19M 0.36% 49
2022
Q2
$421M Buy
8,029,874
+74,191
+0.9% +$3.89M 0.41% 42
2022
Q1
$412M Buy
7,955,683
+543,445
+7% +$28.1M 0.35% 54
2021
Q4
$438M Sell
7,412,238
-151,716
-2% -$8.96M 0.35% 53
2021
Q3
$325M Sell
7,563,954
-1,147,412
-13% -$49.4M 0.29% 62
2021
Q2
$341M Buy
8,711,366
+558,427
+7% +$21.9M 0.31% 57
2021
Q1
$295M Sell
8,152,939
-660,488
-7% -$23.9M 0.3% 59
2020
Q4
$324M Sell
8,813,427
-854,528
-9% -$31.5M 0.36% 52
2020
Q3
$355M Sell
9,667,955
-786,766
-8% -$28.9M 0.44% 42
2020
Q2
$342M Sell
10,454,721
-4,278,478
-29% -$140M 0.46% 38
2020
Q1
$481M Buy
14,733,199
+327,154
+2% +$10.7M 0.76% 17
2019
Q4
$564M Buy
14,406,045
+1,837,440
+15% +$72M 0.72% 21
2019
Q3
$452M Buy
12,568,605
+1,980,253
+19% +$71.2M 0.63% 21
2019
Q2
$459M Buy
10,588,352
+769,699
+8% +$33.3M 0.66% 21
2019
Q1
$417M Sell
9,818,653
-338,238
-3% -$14.4M 0.63% 21
2018
Q4
$443M Sell
10,156,891
-734,402
-7% -$32.1M 0.77% 17
2018
Q3
$480M Buy
10,891,293
+334,410
+3% +$14.7M 0.74% 15
2018
Q2
$383M Buy
10,556,883
+940,153
+10% +$34.1M 0.64% 20
2018
Q1
$341M Buy
9,616,730
+401,662
+4% +$14.3M 0.61% 20
2017
Q4
$334M Buy
9,215,068
+363,546
+4% +$13.2M 0.61% 21
2017
Q3
$316M Buy
8,851,522
+331,993
+4% +$11.9M 0.63% 20
2017
Q2
$286M Buy
8,519,529
+503,898
+6% +$16.9M 0.62% 21
2017
Q1
$274M Buy
8,015,631
+621,555
+8% +$21.3M 0.64% 20
2016
Q4
$240M Buy
7,394,076
+568,547
+8% +$18.5M 0.61% 22
2016
Q3
$231M Buy
6,825,529
+1,078,678
+19% +$36.5M 0.63% 20
2016
Q2
$202M Buy
5,746,851
+384,873
+7% +$13.6M 0.63% 20
2016
Q1
$159M Sell
5,361,978
-166,718
-3% -$4.94M 0.54% 30
2015
Q4
$178M Buy
5,528,696
+639,391
+13% +$20.6M 0.64% 20
2015
Q3
$154M Buy
4,889,305
+434,890
+10% +$13.7M 0.63% 21
2015
Q2
$149M Buy
4,454,415
+654,722
+17% +$22M 0.57% 20
2015
Q1
$132M Buy
3,799,693
+416,282
+12% +$14.5M 0.58% 22
2014
Q4
$105M Buy
3,383,411
+1,142,586
+51% +$35.6M 0.51% 28
2014
Q3
$66.3M Buy
2,240,825
+38,585
+2% +$1.14M 0.38% 45
2014
Q2
$65.4M Buy
2,202,240
+108,606
+5% +$3.22M 0.4% 41
2014
Q1
$67.2M Buy
2,093,634
+87,127
+4% +$2.8M 0.46% 34
2013
Q4
$61.5M Sell
2,006,507
-206,536
-9% -$6.33M 0.46% 32
2013
Q3
$63.6M Buy
2,213,043
+115,792
+6% +$3.33M 0.55% 24
2013
Q2
$58.7M Buy
+2,097,251
New +$58.7M 0.55% 26